Measles Outbreak Cases Cross 100 Mark In US, Australia Sees Sudden Surge Of The Infectious Disease

Updated Feb 23, 2025 | 11:46 AM IST

SummaryMeasles continues to create havoc with over 100 people infected in US. New health guidelines and advisories are being issued to ensure people remain safe and vigilant.
(Credit-Canva)

(Credit-Canva)

The current measles outbreak has gripped US states like Texas and New Mexico leaving people worried whether it would become a new pandemic. According to the Texas Department of State Health Services as of February 21, 90 cases were diagnosed in the last month in the South Plains area, with at least 77 of them were reported in children and teens under 17.

Measles is highly contagious and can be deadly. The outbreak, which started spreading in late January, has resulted in multiple hospitalizations, with at least nine confirmed cases and three probable cases as of early February. Health officials caution that at least one in five infected individuals will have to be hospitalized, highlighting the severity of the situation.

Misinformation surrounding vaccines and with the new Trump administration anti-vaccine campaigs, has causing parents to hesitate or refuse vaccination.

Furthermore, the country down under Australia is also witnessing a surge in measles cases as health officials in Sydney have issued an urgent alert, urging residents to watch for measles symptoms after an infected individual visited several places in Sydney over the last seven days.

Authorities report that the traveller had returned from South East Asia where there are ongoing outbreaks of measles.

What Are The Symptoms Measles?

Key symptoms of measles include fever, a runny nose, sore eyes, and a cough. Typically, a red, blotchy rash appears three to four days later, spreading from the head down to the body. Symptoms can manifest between 7 and 18 days after exposure.

Anyone who experiences these symptoms after potential exposure should immediately contact their doctor or emergency department. It is crucial to call ahead before visiting to avoid potentially exposing others in the waiting room. Dr. Selvey also highlighted that ongoing measles outbreaks are occurring in various parts of the world, making awareness and prompt action essential.

Why It Is Important To Get Vaccinated?

According to CDC everyone should get the MMR vaccine. It protects you from measles, mumps, and rubella. Getting vaccinated helps stop these diseases from spreading. There are two safe MMR vaccines available. They work the same way, so it doesn't matter which one you get. Kids can also get a shot that protects against chickenpox too, but this is only for children.

Who Should Get Vaccinated?

Kids Need Two Shots

All children should get two MMR shots. The first shot should be given when they are between 12 and 15 months old. The second shot should be given when they are between 4 and 6 years old. If needed, the second shot can be given earlier, but it must be at least 28 days after the first shot.

College Students Need to Be Protected

Students going to college or other schools after high school, need two shots if they are not already immune. The shots must be at least 28 days apart.

Adults Need at Least One Shot

Most adults need at least one MMR shot. Some adults need two shots, especially those who work in healthcare, travel a lot, or go to college. These people should get two shots, with 28 days between them.

Travelers Need to Be Extra Careful

Anyone traveling to other countries should make sure they are protected. Babies 6 to 11 months old should get one shot before traveling. Kids 12 months and older, teens, and adults need two shots, with 28 days between them.

Healthcare Workers Must Be Immune

People who work in healthcare should have proof that they are immune to measles, mumps, and rubella. If they are not immune, they need two MMR shots, spaced 28 days apart.

Women Thinking About Having Babies

Women who might get pregnant should talk to their doctor about the MMR vaccine. It's safe to get the shot while breastfeeding.

End of Article

You Can No Longer Buy Medicines Containing More Than 12% Alcohol Over the Counter: Health Ministry

Updated Jul 12, 2026 | 04:08 PM IST

SummaryThe Centre recently amended Drugs Rules, 1945 to prevent the sale of medicines containing more than 12% alcohol directly over the counter.
You Can No Longer Buy Medicines Containing More Than 12% Alcohol Over the Counter: Health Ministry

Credit: AI

In a major regulatory move, the Centre has tightened the rules governing the sale of oral medicinal formulations with high alcohol content. The move is aimed at curbing the misuse of alcohol-containing medicines.

Medicines With Over 12% Alcohol Cannot Be Sold Over The Counter

Under the amended Drugs Rules, 1945, medicines containing more than 12% v/v ethyl alcohol and sold in quantities exceeding 30 mL can no longer be purchased over the counter and will now require a valid prescription from a registered medical practitioner.

The Ministry of Health and Family Welfare announced that these products have been removed from the exemptions provided under Schedule K of the Drugs Rules.

As a result, manufacturers and sellers must now comply with these amendments under the Drugs and Cosmetics Act, 1940, while pharmacies will be allowed to dispense these medicines only against a doctor's prescription.

The amended rules also place these formulations under Schedule H1, a category that mandates stricter controls on the sale of medicines. Pharmacies will be required to maintain detailed records of such sales, including the prescribing doctor's details and the identity of the purchaser.

Also read: Before You Take Another Paracetamol, Read This: Doctors Explain the Hidden Risks

A Step Towards Preventing Misuse

Certain oral formulations, including tinctures of cardamom, ginger and other aromatic preparations, have historically been exempt from licensing requirements despite containing alcohol levels that can reach as high as 80% to 90% by volume.

Officials said these products have increasingly been susceptible to misuse for intoxication, prompting requests from several state governments for tighter regulation.

The Health Ministry emphasized that the new rules are designed to ensure that these medicines remain available for legitimate therapeutic purposes while reducing opportunities for abuse.

By bringing them under the regulated pharmaceutical supply chain, the government expects to improve accountability from manufacturers to retailers and strengthen patient safety.

Not A Blanket Ban On All Alcohol-Containing Medicines

Importantly, the amendment does not amount to a blanket ban on alcohol-containing medicines. Products that contain 12% or less ethyl alcohol, or those packaged in quantities up to 30 mL, are not covered by the new restriction. The revised rules specifically target higher-alcohol formulations sold in larger volumes, which authorities believe carry a greater risk of misuse.

The Ministry also issued clarification about homeopathy medicines that tend to contain high amounts of alcohol. It said that homeopathy already has a similar rule in place since 1994.

Here is section: 106B. [Prohibition of quantity and percentage. [Inserted by G.S.R. 108(E), dated 22.2.1994 (w.e.f. 22.6.1994).] - No Homeopathic medicine containing more than 12% alcohol v/v (Ethyl Alcohol) shall be packed and sold in packing or bottles of more than 30 millilitres, except that it may be sold to hospitals/dispensaries in packings or bottles of not more than 100 millilitres.]

The decision is a push to promote responsible use of medicines while addressing concerns over self-medication and substance misuse.

The government maintains that these regulations will help safeguard public health without affecting access to patients who genuinely need these medicines.

End of Article

Shamita Shetty’s Endometriosis Diagnosis Sparks Concerns About Risks Of Delayed Detection

Updated Jul 12, 2026 | 02:10 PM IST

SummaryShamita Shetty's account of living with endometriosis and perimenopause sheds light on dangers associated with delayed detection like chronic pelvic pain, infertility, bowel and bladder complications and more.
Shamita Shetty’s Endometriosis Diagnosis Sparks Concerns About Risks Of Delayed Detection

Credit: Instagram

Actress Shamita Shetty recently opened up about her endometriosis diagnosis as well as navigating perimenopause. It has sparked concerns about delayed detection of the condition and risks associated with it.

Shamita Shetty’s Endometriosis Diagnosis

Speaking to Soha Ali Khan on her podcast All About Her alongside gynecological surgeon Dr. Neeta Warty, Shetty shared how her symptoms were dismissed repeatedly, leaving her searching for answers until the pain became unbearable and impossible to ignore.

She said that years of unexplained pain delayed her diagnosis, making her question whether what she was experiencing was simply a “normal” part of being a woman.

Shetty said routine medical tests initially failed to confirm the condition. As her health reports checked fine, she assumed her symptoms were ordinary, even as they kept returning.

“I wasn't given the right diagnosis initially,” Shetty said, explaining that she underwent standard gynecological examinations, including Pap smears, but no underlying cause was identified.

The actress said her symptoms intensified significantly in the months leading up to surgery. Although she considers herself to have a high pain tolerance due to previous injuries, she realized something was seriously wrong when the pain began waking her from sleep. After further investigations, she got diagnosed with endometriosis.

Shetty also revealed that she was entering perimenopause around the same time her symptoms of endometriosis worsened, making it difficult to distinguish between hormonal changes and signs of endometriosis.

Also read: World Population Day: How America's Falling Birth Rate Is Redefining Women's Healthcare?

Raising Awareness

Shetty underwent surgery for endometriosis in May 2024 and has since used her platform to encourage women not to ignore persistent pelvic pain.

During the podcast, she also addressed outdated advice that women with endometriosis should “have a baby” to solve the condition, recalling that one doctor suggested pregnancy as a treatment.

Shetty's diagnosis underscores the importance of paying attention to persistent symptoms rather than dismissing them as ordinary menstrual discomfort.

Severe period pain that disrupts daily activities, chronic pelvic pain, pain during intercourse, heavy menstrual bleeding, or difficulty becoming pregnant should be evaluated by a healthcare professional.

About Endometriosis And Perimenopause

Also read: Beyond The Bump: Why Preconceptions And Antenatal Care Are Key To A Healthy Pregnancy

Endometriosis is a chronic condition in which tissue similar to the lining of the uterus grows outside the uterus. The condition often requires long-term management. It can cause symptoms like:

  • Pevere pelvic pain
  • Painful periods
  • Infertility
  • Inflammation

On the other hand, perimenopause, the transitional period before menopause, can bring symptoms such as irregular menstrual cycles, hot flashes, mood changes, sleep disturbances, and hormonal fluctuations.

If diagnosed late, endometriosis can lead to complications like:

  • Chronic pelvic pain that could worsen over time.
  • Reduced fertility or infertility.
  • Progression of the disease that could lead to larger lesions and ovarian cysts.
  • Scar tissue (adhesions) that can cause organs to stick together.
  • More complex surgeries.
  • Bowel or bladder complications if the disease spreads beyond the uterus.
  • Mental health effects, including anxiety, depression, and poor quality of life.

Recent Advancements In Endometriosis Diagnosis

According to the World Health Organization, endometriosis affects around 190 million women and girls worldwide, or 1 in 10 women of reproductive age.

The organization notes that many women experience diagnostic delays because symptoms are frequently normalized or mistaken for other conditions.

To curb this, the National Institute for Health and Care Excellence's (NICE) recently rolled out two non-invasive tests — the saliva-based Endotest and the gut sensor-based EndoSure — to help speed up the diagnosis of endometriosis in England and Wales.

Endotest analyses a saliva sample to identify tiny biological markers called microRNAs that can indicate whether endometriosis is likely to be present.

EndoSure is a non-invasive test that detects endometriosis by measuring electrical signals in the gut using sensor pads placed on the abdomen.

For this test, patients fast for six to eight hours before the test and drink water until full during the 45-minute procedure to help the device accurately record gut activity. Results are available immediately after the test.

End of Article

US Humanitarian Worker Tests Positive For Ebola As Congo Outbreak Tops 1,800 Cases

Updated Jul 12, 2026 | 12:15 PM IST

SummaryAmid rising cases and slow containment efforts in Congo, a humanitarian volunteer from the United States recently tested positive for Ebola.
US Humanitarian Worker Tests Positive for Ebola as Congo Outbreak Tops 1,800 Cases

Credit: iStock

A U.S. humanitarian worker in the Democratic Republic of the Congo (DRC) has tested positive for Ebola, raising fresh concerns as the country struggles with one of the worst Ebola outbreaks.

US Humanitarian Worker In DRC Tests Positive For Ebola

On Friday, the U.S. Centers for Disease Control and Prevention (CDC) confirmed, saying it is working closely with the individual's employer, U.S. government health agencies, and Congolese health authorities to prevent further transmission by tracing contacts to identify people who may have been exposed.

According to reports, the infected individual was working for a humanitarian organization in eastern Congo, where the outbreak has continued to spread despite ongoing response efforts.

The CDC has not released details about the patient's identity or condition but emphasized that contact tracing and public health measures are underway.

A spokesperson for the U.S. State Department said it is aware of the case and is assisting the affected American.

The spokesperson said, “A U.S. citizen working for a humanitarian organization in the Democratic Republic of the Congo has tested positive for the Bundibugyo strain of the Ebola virus. The CDC is working with the patient's employing organization, other federal agencies and partners in the Democratic Republic of the Congo to help prevent further transmission and identify high-risk contacts.”

The health regulatory body further said, “The risk of Ebola spreading in the United States remains low.”

Also read: Ebola In DRC Is Still In ‘Expansion Phase’: WHO Doctor Opens About Major Challenges In Containing The Outbreak

Ebola Outbreak In DRC: Latest Updates

The case comes as the Democratic Republic of the Congo faces an escalating Ebola crisis. According to the Africa CDC, the outbreak has now reached 1,830 confirmed cases and 648 deaths, making it the fastest-growing Ebola outbreak ever recorded on the continent. The outbreak was officially declared on May 15, 2026, and has spread across multiple provinces in eastern Congo.

Health officials say this outbreak is particularly concerning because it is caused by the Bundibugyo strain of the Ebola virus, a rare variant for which there is currently no approved vaccine or specific antiviral treatment.

WHO Says Actual Number Of Cases Could Be Higher

The World Health Organization (WHO) has also warned that the official case count may significantly underestimate the true scale of the outbreak.

WHO modeling suggests that actual infections could be two to four times higher than reported because many cases are not being detected.

Nearly 80% of newly identified infections in some of the hardest-hit communities cannot be linked to known Ebola patients, indicating widespread community transmission.

The agency also reported that about 70% of deaths early in the outbreak occurred outside treatment centers, making surveillance and contact tracing even more difficult.

WHO Emergencies Director Chikwe Ihekweazu told Reuters, “Eighty percent of the new patients confirmed are coming outside of known contact lists” in Bunia, the epicenter of the outbreak, highlighting widespread undetected transmission.

He also warned, “The true scale of the outbreak is likely two to four times larger than the official figures suggest.”

The latest case highlights the dangers faced by frontline aid workers and underscores the urgency of strengthening outbreak control measures before the virus spreads further.

With no approved vaccine for the Bundibugyo strain and transmission continuing in several provinces, global health officials say rapid detection, isolation, and international cooperation remain essential to bringing the outbreak under control.

End of Article